QuVa Pharma Expands Leadership Team with Appointment of Industry Veteran Scott Aladeen as Chief Operating Officer

QuVa Pharma Expands Leadership Team with Appointment of Industry Veteran Scott Aladeen as Chief Operating Officer
Enhanced Management Team Strengthen Governance of its Rapidly Growing, National business
News provided by
Share this article
Share this article
SUGAR LAND, Texas, April 1, 2021 /PRNewswire/ -- QuVa Pharma, Inc., a leading 503B outsourcing services company to healthcare facilities, has tapped pharmaceutical industry veteran Scott Aladeen as its new Chief Operating Officer. The move comes as the company has tripled production of critical medicines needed by U.S. hospitals, especially amidst the COVID-19 pandemic. 
"At a time when hospitals are increasingly making FDA registered 503B outsourcing companies an essential component of their pharmaceutical supply chain, it's critical we continue to invest in experienced and innovative leaders who have deep FDA-based pharmaceutical quality and manufacturing expertise," said Stuart Hinchen, CEO & Co-founder of QuVa Pharma. "As part of our commitment to patient safety, Scott strengthens the governance of our rapidly growing national business and expands critical oversight."

Related Keywords

Texas ,United States ,Sugar Land ,Scott Aladeen ,Stuart Hinchen ,Quva Pharma ,Peter Jenkins ,Quva Pharma Inc ,Quva Pharma Customer Service ,Avara Pharmaceutical Services ,Chief Operating ,Chief Development Officer ,Inc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Outsourcing Businesses ,Pharmaceuticals ,Personnel Announcements ,டெக்சாஸ் ,ஒன்றுபட்டது மாநிலங்களில் ,சர்க்கரை நில ,ஸ்டூவர்ட் ஹின்செங் ,பீட்டர் ஜென்கின்ஸ் ,அவரை மருந்து சேவைகள் ,தலைமை இயங்குகிறது ,தலைமை வளர்ச்சி அதிகாரி ,இன்க் ,ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் ,மருத்துவ மருந்துகள் ,ஔட்‌ஸ்ர்ஸிஂக் வணிகங்கள் ,மருந்துகள் ,பணியாளர்கள் அறிவிப்புகள் ,